N@N

Bernstein Liebhard LLP Announces Investigation of Offer for Cephalon, Inc.

_{//health-fitness.news-articles.net/content/2011/ .. ces-investigation-of-offer-for-cephalon-inc.html}
^{Published in Health and Fitness on Wednesday, March 30th 2011 at 7:55 GMT by Market Wire}  

NEW YORK--([ BUSINESS WIRE ])--Bernstein Liebhard LLP is investigating whether the Board of Directors of Cephalon, Inc. (aCephalona or the aCompanya) (Nasdaq: CEPH) is breaching its fiduciary duty to its shareholders in failing to embrace premium offers for the company by Valeant Pharmaceuticals International, Inc. (aValeant Pharmaceuticalsa).

As reported, Cephalon shareholders would receive $73.00 in cash for each share they own. The investigation is focused on Cephalona™s failing to embrace Valeant Pharmaceuticalsa™ offers.

If you are interested in discussing your rights as a Cephalon shareholder and/or have information relating to the matter, please contact Joseph R. Seidman, Jr. at (877) 779-1414 or [ seidman@bernlieb.com ].

Bernstein Liebhard has pursued hundreds of securities, [ consumer ] and shareholder rights cases and recovered almost $3 billion for its clients. It has been named to The National Law Journala™s aPlaintiffsa™ Hot Lista in each of the last eight years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414
[ www.bernlieb.com ]

ATTORNEY ADVERTISING. © 2011 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.